These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 240264

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. [Conservative therapy in the Parkinson syndrome].
    Birkmayer W.
    Wien Med Wochenschr; 1971 Nov 13; 121(46):827-9. PubMed ID: 5138823
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. [Interaction between L-dopa and other drugs].
    Pakszys W.
    Pol Tyg Lek; 1976 Nov 22; 31(47):2031-4. PubMed ID: 995746
    [No Abstract] [Full Text] [Related]

  • 47. Update on antiparkinsonian agents.
    Weiner M.
    Geriatrics; 1982 Sep 22; 37(9):81-4, 89-91. PubMed ID: 6125455
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Restatement and prospectives of ergot alkaloids in clinical neurology and psychiatry.
    Agnoli A, Ruggieri S, Casacchia M.
    Pharmacology; 1978 Sep 22; 16 Suppl 1():174-88. PubMed ID: 347463
    [No Abstract] [Full Text] [Related]

  • 51. Parkinson's disease.
    Barboi AC, Goetz CG.
    Clin Neuropharmacol; 1999 Sep 22; 22(4):184-91. PubMed ID: 10442246
    [No Abstract] [Full Text] [Related]

  • 52. [Recent advances and pharmacological basis of the medical treatment of Parkinson's syndrome].
    Shibazaki H.
    Shinkei Kenkyu No Shimpo; 1971 Sep 22; 15(4):992-1002. PubMed ID: 4400830
    [No Abstract] [Full Text] [Related]

  • 53. Pharmacotherapy of Parkinson's disease.
    Cohen MM, Scheife RT.
    Am J Hosp Pharm; 1977 May 22; 34(5):531-8. PubMed ID: 326045
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Four-year treatment of patients with parkinsonism using amantadine alone or with levodopa.
    Timberlake WH, Vance MA.
    Ann Neurol; 1978 Feb 22; 3(2):119-28. PubMed ID: 350129
    [Abstract] [Full Text] [Related]

  • 56. The L-dopa sparing effect of G 31,406 in the treatment of parkinson's disease.
    Couto B, Oliveira C, Mattos JP, Freitas MR.
    Neurol Neurocir Psiquiatr; 1976 Feb 22; 17(4):285-92. PubMed ID: 798128
    [Abstract] [Full Text] [Related]

  • 57. [Therapy and problems of parkinsonism].
    Albert E.
    Nervenarzt; 1971 May 22; 42(5):225-41. PubMed ID: 4942900
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.